Interleukin 12: A key modulator of immune function

Publisher Website
Google Scholar
Abstract
Interleukin (IL)‐12 was cloned on the basis of its ability to activate natural killer (NK) cells and promote the development of cytolytic T cells. With further understanding of its activities, IL‐12 has emerged as an important cytokine, affecting both immune and hematologic functions. It has been shown to be necessary for the T cell independent induction of interferon (IFN)‐γ, critical for the initial suppression of bacterial and parasitic infection; for the development of a Th1 response, critical for effective host defense against intracellular pathogens; and for the activation of differentiated T lymphocytes of both CD4+ and CD8+ phenotype. IL‐12 thus functions to activate and to link the innate and acquired immune responses. The therapeutic potential of these activities is suggested by studies in tumor and microbial models. IL‐12 has suppressed tumor growth in all murine models examined. Antimicrobial activity has been demonstrated in bacterial, yeast, parasitic, and viral models of infection. In many of these models, activity has been linked to production of IFN‐γ and, in the parasite model, to development of a Th1 response. In addition to the therapeutic potential associated with IL‐12 activity in these disease models, the understanding of its role in immune development and interaction with other cytokines, particularly antagonists, such as IL‐4 and IL‐10, has clarified and extended our understanding of immune regulation and should lead to significant developments in understanding the progression of AIDS and the development of vaccine adjuvants able to direct the immune response.

This publication has 57 references indexed in Scilit: